Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
> www.clinicaltrials.gov. Once you are on the website, type “NCT03152084”
into the search box and click “Search”.
> www.clinicaltrialsregister.eu. Once you are on the website, click
“Home and Search”, then type “2016-002961-79” in the search
box and click “Search”.
> www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D1690C00049” into the search box, and click “Find a Study”.
Full Study Trial: DAPASALT: An Open Label, Phase IV, Mechanistic, Three-Arm Study to
Evaluate the Natriuretic Effect of 2-Week Dapagliflozin treatment in Type 2 Diabetes Mellitus
Patients with Either Preserved or Impaired Renal Function and Non-Diabetics with Impaired
Renal Function
AstraZeneca AB Protocol Number: D1690C00049
AstraZeneca AB sponsored this study and has its headquarters at
151 85 Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Participants in clinical studies belong to a large community of people who take
part in clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_01_08
8 | Clinical Study Results